This site has been produced by Kite, a Gilead Company

Neurologic adverse reactions

Neurologic adverse reactions refer to a range of side effects that may affect the brain or central nervous system.

They are a common side effect of your prescribed CAR T-cell therapy, caused by the body reacting to the CAR T-cells.

It’s important to receive treatment for neurologic adverse reactions as soon as possible. Your healthcare team will monitor you closely and will help to identify if you are having a reaction. If you do experience more severe side effects, you may be moved to the Intensive Care Unit (ICU) to ensure you get the best possible care. More information on the ICU can be found here.

Tell your doctor or healthcare team straight away if you notice any of the following signs and symptoms:

Bullet
Confusion and disorientation
Bullet
Difficulty speaking
Bullet
Difficulty understanding speech
Bullet
Difficulty understanding numbers
Bullet
Memory loss
Bullet
Tremors (shaky arms or body parts)
Bullet
Agitation
Bullet
Increased sleepiness
Bullet
Dizziness
Bullet
Fits
Bullet
Loss of consciousness
Bullet
Loss of balance or coordination

Change in handwriting

A major change in your handwriting could indicate the onset of neurologic adverse reactions. Before treatment, write a simple phrase in a notebook. After treatment, write the same phrase next to it and notice whether your handwriting is any different. You can also ask someone close to you or a member of your healthcare team to pay special attention to your handwriting in the weeks following treatment.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

United Kingdom: Reporting of side effects

For patients residing in the United Kingdom, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of your medicine.

Republic of Ireland: Reporting of side effects

For patients residing in the Republic of Ireland, you can also report side effects directly via the HPRA website at www.hpra.ie. By reporting side effects, you can help provide more information on the safety of your medicine.

This site is a patient information resource, intended only for patients residing in the United Kingdom and Ireland who are being referred for or have been prescribed CAR T-cell therapy by their healthcare professional. This site has been developed and paid for by Kite, a Gilead Company.

This site has been produced by Kite, a Gilead Company

© 2024 Gilead Sciences, Inc. All rights reserved. KITE and the Kite logo are registered trademarks of Kite Pharma, Inc | GILEAD is a registered trademark of Gilead Sciences, Inc and its related companies

UK-UNB-3795 April 2023